Antianginal Tx Fails to Make a Difference After Coronary Stenting

(MedPage Today) -- After successful percutaneous coronary intervention (PCI), prophylactic use of trimetazidine on top of optimal medical therapy offered no additional relief from chest pain nor reduction in cardiac risk, the ATPCI trial showed...